Medical R&D timelines are being reduced by 30-80% through AI application to drug targeting and novel drug use case discovery, where AI searches through past academic papers and chemical structures to identify novel targets for existing drugs, providing a simpler profitability path than developing entirely new drugs.

factualpending

Speaker

Unidentified Speaker — AI Trends 2025: Mary Meeker Deck Deep Dive Part 1 [_g1LFxC31EY]

Evidence Quote

“30 to 80% reduction in medical R&D timelines which is wild. This one doesn't get publicized enough.”

Source

AI Trends 2025: Mary Meeker Deck Deep Dive Part 1— AI News & Strategy Daily | Nate B Jones
Created: 8/11/2026, 7:38:24 AM

Your notes

Loading notes...